SCHEMBL754517

SCHEMBL754517

O=S(=O)(Cc1ccccc1Br)C(Br)Br

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.41
IDO1 P14902 2/20 0.39
PLCG1 P19174 1/20 0.39
HPGD P15428 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA1 P00915 6/20 0.38
CA2 P00918 6/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA12 O43570 5/20 0.36
CA9 Q16790 5/20 0.36
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.35
THPO P40225 1/20 0.35
TSHR P16473 1/20 0.34
ALDH1A1 P00352 1/20 0.33
CYP2A13 Q16696 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5661830 0.79 TAAR1 (0.46) TAAR1IDO1PLCG1HPGDL3MBTL1
SCHEMBL754045 0.78 ALDH1A1 (0.49) TAAR1IDO1HPGDLMNATSHR
SCHEMBL753514 0.78 ALDH1A1 (0.44) TAAR1IDO1HPGDCA2LMNA
SCHEMBL29355999 0.75 HPGD (0.44) TAAR1IDO1PLCG1HPGDL3MBTL1
SCHEMBL271620 0.75 HPGD (0.44) TAAR1IDO1PLCG1HPGDL3MBTL1
SCHEMBL2396949 0.75 TAAR1 (0.44) TAAR1IDO1PLCG1HPGDL3MBTL1
SCHEMBL11379944 0.75 CA2 (0.50) TAAR1IDO1PLCG1HPGDL3MBTL1
SCHEMBL10654193 0.75 TAAR1 (0.43) TAAR1IDO1PLCG1HPGDL3MBTL1
SCHEMBL9300506 0.75 TAAR1 (0.43) TAAR1IDO1PLCG1HPGDL3MBTL1
SCHEMBL2396946 0.75 TAAR1 (0.43) TAAR1IDO1PLCG1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M TAAR1 2058/4885IDO1 310/4885PLCG1 2321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.